
New data on antiviral efficacy against SARS-CoV-2 variants
Marinomed Biotech, an Austrian biotech company, has announced results of the antiviral efficacy of iota-carrageenan (Carragelose) against the original SARS-CoV-2 strain and variants of concern (VOC), including the Delta variant. This has been published in the International Journal of Molecular Sciences. Collaboration The peer-reviewed study is… Read More














